These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 8142585
1. Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2. Goudreau N, Weng JH, Roques BP. Biopolymers; 1994 Feb; 34(2):155-69. PubMed ID: 8142585 [Abstract] [Full Text] [Related]
2. Comparative conformational analysis of CCK-B agonist Boc-Trp-Phg-Asp-(1-Nal)-NH2 and CCK1-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 using 1HNMR spectroscopy and restrained molecular dynamics. Goudreau N, Weng JH, Roques BP. Arch Pharm (Weinheim); 1996 Apr; 329(4):197-204. PubMed ID: 8669984 [Abstract] [Full Text] [Related]
3. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors. Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ. J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778 [Abstract] [Full Text] [Related]
4. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors. Shiosaki K, Lin CW, Kopecka H, Bianchi B, Miller T, Stashko M, Witte D. J Med Chem; 1997 Mar 28; 40(7):1169-72. PubMed ID: 9089338 [Abstract] [Full Text] [Related]
5. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP. J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851 [Abstract] [Full Text] [Related]
6. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors. Charpentier B, Dor A, Roy P, England P, Pham H, Durieux C, Roques BP. J Med Chem; 1989 Jun 28; 32(6):1184-90. PubMed ID: 2724293 [Abstract] [Full Text] [Related]
8. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones. Stone SR, Giragossian C, Mierke DF, Jackson GE. Peptides; 2007 Nov 28; 28(11):2211-22. PubMed ID: 17950490 [Abstract] [Full Text] [Related]
10. Conformational behavior of cyclic CCK-related peptides determined by 400-MHz 1H-NMR: relationships with affinity and selectivity for brain receptors. Roy P, Charpentier B, Durieux C, Dor A, Roques BP. Biopolymers; 1989 Jan 28; 28(1):69-79. PubMed ID: 2720122 [Abstract] [Full Text] [Related]
11. Conformationally readdressed CCK-B/delta-opioid peptide ligands. Nikiforovich GV, Kolodziej SA, Nock B, Bernad N, Martinez J, Marshall GR. Biopolymers; 1995 Oct 28; 36(4):439-52. PubMed ID: 7578939 [Abstract] [Full Text] [Related]
15. Conformational and structural analysis of the equilibrium between single- and double-strand beta-helix of a D,L-alternating oligonorleucine. Navarro E, Fenude E, Celda B. Biopolymers; 2004 Feb 05; 73(2):229-41. PubMed ID: 14755580 [Abstract] [Full Text] [Related]